Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for Dysphagia in Systemic Sclerosis
NCT06915181Phase 2Withdrawn
- Sponsor
- UZ Brussel
- Start
- Dec 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pyridostigmine in dysphagia, sponsored by UZ Brussel. Planned start Dec 2023; status: withdrawn.
02
Drugs
pyridostigmine
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT06915181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915181.